Advertisement

The Latest

An AI-powered machine learning tool may allow physicians to better identify origins in enigmatic cancers, according to researchers at the Massachusetts Institute of Technology in Cambridge, Mass., and Dana-Farber Cancer Institute in Boston. 

Detroit-based Barbara Ann Karmanos Cancer Institute, a McLaren Health Care-owned facility, has named Boris Pasche, MD, PhD, as the center's new president and CEO, according to an Aug. 7 news release.

Three more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.

While still in contract negotiations, registered nurses at Dana-Farber Cancer Institute - Merrimack Valley in Methuen, Mass., voted 33 to 1 to authorize a one-day strike, the Massachusetts Nurses Association said in an NBC Boston report. 

Researchers at Los Angeles-based City of Hope recently announced promising results for a new chemotherapy pill that "appears to annihilate all solid tumors," according to research published Aug. 1 in Cell Chemical Biology. 

Advertisement